It activates the Ca2+/calmodulin-dependent protein kinase II (CaMKII) pathway, inhibits mitochondrial apoptosis by reducing the Bax/Bcl-2 ratio, and promotes glioma cell survival (44). The gene discussed is CAMK2G; the disease is glioma.